Michael Troullis has now been officially given the job of chief operating officer (CFO) of Quintiles and will continue reporting to the chairman and chief executive officer (CEO), Dennis Gillings.
Troullis has been acting in the position of CFO since last year, when he replaced the former CFO John Ratliff, when he was promoted to chief operating officer (COO).
Prior to his appointment as acting CFO, Troullis was senior vice president and worldwide controller of Quintiles.
At smaller rival contract organisation (CRO) Pharmaceutical Product Development (PPD), Susan Atkinson has become the new senior vice president for global biostatistics and data management.
Atkinson has started with the company as a senior biostatistician in 1991 and has since worked her way up the ladder.
UK-based Premier Research has also recently appointed Chris Nowell as vice president of International Clinical Trial Management.
Prior to this he served as director of Project Management at Quintiles.
In his new role at Premier, Nowell will be responsible for the development of standards, systems, processes, and training for the both clinical project management and clinical monitoring functions.
Canadian contract manufacturer PharmEng International has hired David Leonard as president of its subsidiary company Keata Pharma.
He most recently worked in business development for Trillium Health Care Products.
At Keata, Leonard will oversee the company's manufacturing facilities in Perth, Ontario along with a new site in Sydney, Nova Scotia, scheduled to open in the fourth quarter of this year.
Leonard takes over the role from Bernie Boudreau who has been promoted to vice president of corporate development and legal affairs at PharmEng.
Meanwhile, Chinese firm WuXi PharmaTech has also been continuing its employment drive, filling three senior level positions this week, including the appointment of an executive vice president of operations at the firm.
The new incumbent has been named as Edward Hu , who will take on his new role at the R&D outsourcing outfit reporting to the company CEO, Ge Li.
Hu previously held positions at Tanox (recently acquired by Genentech), Biogen Idec and Merck.